A Graffi

1.8k total citations
172 papers, 988 citations indexed

About

A Graffi is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, A Graffi has authored 172 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 31 papers in Immunology and 27 papers in Genetics. Recurrent topics in A Graffi's work include Virus-based gene therapy research (18 papers), Immunotherapy and Immune Responses (12 papers) and T-cell and Retrovirus Studies (8 papers). A Graffi is often cited by papers focused on Virus-based gene therapy research (18 papers), Immunotherapy and Immune Responses (12 papers) and T-cell and Retrovirus Studies (8 papers). A Graffi collaborates with scholars based in Germany, Austria and Romania. A Graffi's co-authors include Fey F, V. Wunderlich, Michael Böttger, Friedrich Hoffmann, Ursula Heine, Thomas Schramm, Erich Schneider, H. Kriegel, Frank Hoffmann and J. Helmcke and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Biochemical and Biophysical Research Communications.

In The Last Decade

A Graffi

146 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Graffi Germany 13 388 215 201 162 138 172 988
Cedric W. Long United States 16 627 1.6× 224 1.0× 150 0.7× 139 0.9× 211 1.5× 39 960
H.M. Keir United Kingdom 23 919 2.4× 255 1.2× 94 0.5× 163 1.0× 462 3.3× 59 1.5k
Bertram M. Gesner United States 17 439 1.1× 68 0.3× 422 2.1× 72 0.4× 115 0.8× 18 1.1k
A. Feinstein United Kingdom 16 722 1.9× 144 0.7× 403 2.0× 135 0.8× 149 1.1× 24 1.4k
K. H. Fantes United Kingdom 19 374 1.0× 66 0.3× 350 1.7× 221 1.4× 119 0.9× 34 973
R. Yamamoto Australia 14 506 1.3× 93 0.4× 461 2.3× 139 0.9× 199 1.4× 23 1.2k
Arpi Hagopian United States 18 846 2.2× 117 0.5× 135 0.7× 65 0.4× 201 1.5× 25 1.2k
Marilyn R. Loeb United States 16 680 1.8× 157 0.7× 62 0.3× 178 1.1× 416 3.0× 23 1.4k
Richard K. Bestwick United States 21 749 1.9× 447 2.1× 137 0.7× 78 0.5× 150 1.1× 34 1.3k
Sujata Manam United States 16 809 2.1× 249 1.2× 371 1.8× 161 1.0× 142 1.0× 23 1.3k

Countries citing papers authored by A Graffi

Since Specialization
Citations

This map shows the geographic impact of A Graffi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Graffi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Graffi more than expected).

Fields of papers citing papers by A Graffi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Graffi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Graffi. The network helps show where A Graffi may publish in the future.

Co-authorship network of co-authors of A Graffi

This figure shows the co-authorship network connecting the top 25 collaborators of A Graffi. A scholar is included among the top collaborators of A Graffi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Graffi. A Graffi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Graffi, A, et al.. (1978). Experiments to increase the selectivity of tumor chemotherapy by means of in vivo activation of transport forms of cancerostatics by exogenous enzymes.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 25(4). 377–84.
2.
Graffi, A, et al.. (1978). [Isolation of foamy virus type II out of haematopoetic cells from baboons with haematoblastoses and from healthy animals (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 48(2). 97–111. 2 indexed citations
3.
Tschiersch, B, et al.. (1977). Selective tumor DNA synthesis inhibition: in vivo prodrug activation by an exogenous enzyme.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 61(8). 1489–93. 1 indexed citations
4.
Graffi, A, et al.. (1976). [Enzymatically cleavable specific transport forms of cancerostatics. 3. 4-/N.N-bis-(2-chlorethyl)-amino/-derivatives of phenyl-O-beta-D-cellobiosids and pyrocatechol-bis-/O-beta-D-cellobiosids].. PubMed. 31(7). 438–41. 1 indexed citations
5.
Graffi, A, et al.. (1974). [Mesotheliomas in golden hamster. IV. Further studies on the macroscopy and histology including a literature survey (author's transl)].. PubMed. 43(1). 22–35. 1 indexed citations
6.
Graffi, A. (1974). Versuche zur selektiven Giftung von Transportformen von Kanzerostatika im Tumorgewebe durch gleichzeitig applizierte koerperfremde Enzyme. MDC Repository (Max-Delbrueck-Center for Molecular Medicine). 1 indexed citations
7.
Arnold, W. & A Graffi. (1974). [Mechanisms of experimental hematogenous metastasis and its dependence on the reactive defense in the host organism].. PubMed. 7(4). 216–27.
8.
Arnold, W. & A Graffi. (1972). Experimental metastasizing in syngeneic and autochthonous tumour-host systems.. PubMed. 29(6). K7–K13.
9.
Schramm, Thomas, et al.. (1972). [Electron microscopy studies of the papova (papilloma) virus in the golden hamster].. PubMed. 40(6). 191–236. 1 indexed citations
10.
Wetzel, Ronald, et al.. (1969). [Sensitivity of mammalian cells to ultraviolet rays in vitro].. PubMed. 33(4). 319–30.
11.
Prokop, O, et al.. (1968). ["Immunochemical endgrouping" with Helix agglutinins of ascites tumor cells. Comparison with the blood cells of animals].. PubMed. 20(3). Suppl:K9–K15. 6 indexed citations
12.
Böttger, Michael, et al.. (1968). [On the sedimentation behavior of mitochondrial DNA in stabilizing D2O gradients].. PubMed. 21(5). 587–93. 2 indexed citations
13.
Graffi, A. (1967). [Studies on the problem of the importance of mitochondria in carcinogenesis].. PubMed. 22(49). 2305–12. 3 indexed citations
14.
Graffi, A, Fey F, & Thomas Schramm. (1966). Experiments on the hematologic diversification of viral mouse leukemias.. PubMed. 22. 21–31. 5 indexed citations
15.
Graffi, A, et al.. (1961). Notizen: Versuche zum Nachweis gemeinsamer Antigenkomponenten beim Virus der myeloischen und der lymphatischen Leukämie der Maus. Zeitschrift für Naturforschung B. 16(1). 73–74. 1 indexed citations
16.
Graffi, A. (1960). Viren als Ursache von Leukämien. Annals of Hematology. 6(1). 1–7. 4 indexed citations
17.
Schneider, Erich, et al.. (1957). Weitere Untersuchungen �ber die Beziehung zwischen Mitochondrien und Glykolyse. Die Naturwissenschaften. 44(16). 446–446. 3 indexed citations
18.
Graffi, A, et al.. (1957). Untersuchungen �ber den Mechanismus der Glykolysestimulierung durch Mitochondrien. Die Naturwissenschaften. 44(3). 66–67.
19.
Graffi, A, et al.. (1956). Leukämieerzeugung durch ein filtrierbares Agens aus malignen Tumoren. Acta Haematologica. 15(3). 145–174. 49 indexed citations
20.
Graffi, A, et al.. (1955). Leuk�mien bei der Maus nach Injektion von homologen Geschwulstfiltraten. Die Naturwissenschaften. 42(13). 399–399. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026